NCT03050736 2025-09-04Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT ExpressionKintara Therapeutics, Inc.Phase 2 Completed29 enrolled
NCT02717962 2025-08-29Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent SettingKintara Therapeutics, Inc.Phase 2 Completed118 enrolled